Blood Donors Deferral Prevalence and Causes in a Tertiary Health Care Hospital, Southern Nigeria

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2019 Jul 24

PMID 31331326

Citations 13

Authors

Henshaw Uchechi Okoroiwu

Enosakhare Aiyudubie Asemota

Affiliations

Soon will be listed here.

Abstract

Background: Blood transfusion is a life-saving intervention. However, the safety of the donor and the recipient is paramount. This study was aimed at determining the blood donation deferral pattern of University of Calabar Teaching Hospital.

Methods: A retrospective analysis of the prospective donors' data of University of Calabar Donor clinic within the period of March 2015 to February 2016 was conducted. Data were extracted from the donor register and analyzed. Prospective donors were screened and interviewed for causes of temporary and permanent deferrals.

Result: Out of the 1886 screened prospective donors, 164 (8.69%) were deferred. Though the minority of the donor population, female donors had the highest deferral rate (33.33%). There were 31.10 and 68.90% cases of temporary and permanent deferrals, respectively. Hepatitis B virus (HBV) was the highest (31.71%) cause of overall deferral as well as permanent deferral. Anemia was the major (21.95%) cause of temporary deferral as well as the second cause of overall deferrals. Commercial and replacement donors constituted 68.28 and 31.71% of the deferral cases, respectively.

Conclusion: HBV was found to be the overall leading cause of deferral in the studied area. This outcome poses a public health concern and should elicit measures to curb the infection rate.

Citing Articles

Causes of pre and post-donation deferrals among blood donors, at Kwale Satellite Blood Transfusion Center, Kwale County, Kenya, 2018-2022.

Nyamu G, Shee M, Kiende P, Muthiani B, Nakazea R, Mwasowa N BMC Public Health. 2024; 24(1):2197.

PMID: 39138457 PMC: 11321081. DOI: 10.1186/s12889-024-19535-1.

Evaluation of Diagnostic Efficacy of Novel Red Blood Cell Parameters as Potential Screening Test for Detecting Latent Iron Deficiency in Blood Donors.

Shukla A, Awasthi N, Sharma P, Tiwari V, Sharma V, Kulshrestha M Indian J Hematol Blood Transfus. 2024; 40(1):139-145.

PMID: 38312185 PMC: 10831009. DOI: 10.1007/s12288-023-01683-w.

REASONS FOR DEFERRAL IN DEFERRED VOLUNTARY BLOOD DONORS IN EASTERN CROATIA.

Cipek V, Ferenac Kis M, Ratic D, Piskorjanac S, Samardzija M, Kralik K Acta Clin Croat. 2024; 62(1):93-105.

PMID: 38304378 PMC: 10829957. DOI: 10.20471/acc.2023.62.01.12.

Diagnostic and prognostic value of c-MYC gene expression in hematological malignancies.

Okafor I, Okoroiwu H, Ogar C Afr Health Sci. 2024; 23(2):265-273.

PMID: 38223598 PMC: 10782349. DOI: 10.4314/ahs.v23i2.30.

The Prevalence of Transfusion-Transmitted Diseases Among Blood Donors in the Central Blood Bank in Makkah, Saudi Arabia.

Albshri M, Manikandan P, Allahyani M, Aljuaid A, Almehmadi M, Alzabeedi K Cureus. 2023; 15(11):e48881.

PMID: 38106789 PMC: 10724763. DOI: 10.7759/cureus.48881.

References

Newman B . Blood donor suitability and allogeneic whole blood donation. Transfus Med Rev. 2001; 15(3):234-44. DOI: 10.1053/tmrv.2001.24593. View

Cancado R, Chiattone C, Alonso F, Langhi Junior D, Alves R . Iron deficiency in blood donors. Sao Paulo Med J. 2001; 119(4):132-4; discussion 131. PMC: 11164459. DOI: 10.1590/s1516-31802001000400003. View

Custer B, Johnson E, Sullivan S, Hazlet T, Ramsey S, Hirschler N . Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004; 44(10):1417-26. DOI: 10.1111/j.1537-2995.2004.04160.x. View

Mittal R, Marwaha N, Basu S, Mohan H, Ravi Kumar A . Evaluation of iron stores in blood donors by serum ferritin. Indian J Med Res. 2007; 124(6):641-6. View

Custer B, Chinn A, Hirschler N, Busch M, Murphy E . The consequences of temporary deferral on future whole blood donation. Transfusion. 2007; 47(8):1514-23. DOI: 10.1111/j.1537-2995.2007.01292.x. View

Arslan O . Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007; 17(5):379-83. DOI: 10.1111/j.1365-3148.2007.00738.x. View

Ahmed S, Ibrahim U, Hassan A . Adequacy and pattern of blood donations in north-eastern Nigeria: the implications for blood safety. Ann Trop Med Parasitol. 2007; 101(8):725-31. DOI: 10.1179/136485907X241442. View

Mast A, Foster T, Pinder H, Beczkiewicz C, Bellissimo D, Murphy A . Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors. Transfusion. 2008; 48(10):2197-204. DOI: 10.1111/j.1537-2995.2008.01823.x. View

Zou S, Musavi F, Notari E, Rios J, Trouern-Trend J, Fang C . Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion. 2008; 48(12):2531-9. DOI: 10.1111/j.1537-2995.2008.01903.x. View

10.

Bahadur S, Jain S, Goel R, Pahuja S, Jain M . Analysis of blood donor deferral characteristics in Delhi, India. Southeast Asian J Trop Med Public Health. 2009; 40(5):1087-91. View

11.

Buseri F, Muhibi M, Jeremiah Z . Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus. 2009; 7(4):293-9. PMC: 2782806. DOI: 10.2450/2009.0071-08. View

12.

Mast A, Schlumpf K, Wright D, Custer B, Spencer B, Murphy E . Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion. 2010; 50(8):1794-802. PMC: 3003699. DOI: 10.1111/j.1537-2995.2010.02649.x. View

13.

Agnihotri N . Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci. 2010; 4(2):116-22. PMC: 2937288. DOI: 10.4103/0973-6247.67035. View

14.

Custer B, Schlumpf K, Wright D, Simon T, Wilkinson S, Ness P . Donor return after temporary deferral. Transfusion. 2010; 51(6):1188-96. PMC: 3536538. DOI: 10.1111/j.1537-2995.2010.02989.x. View

15.

Stokx J, Gillet P, De Weggheleire A, Casas E, Maendaenda R, Beulane A . Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infect Dis. 2011; 11:141. PMC: 3120673. DOI: 10.1186/1471-2334-11-141. View

16.

Cable R, Glynn S, Kiss J, Mast A, Steele W, Murphy E . Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011; 52(4):702-11. PMC: 3618489. DOI: 10.1111/j.1537-2995.2011.03401.x. View

17.

Ott J, Stevens G, Groeger J, Wiersma S . Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12):2212-9. DOI: 10.1016/j.vaccine.2011.12.116. View

18.

Mast A, Steele W, Johnson B, Wright D, Cable R, Carey P . Population-based screening for anemia using first-time blood donors. Am J Hematol. 2012; 87(5):496-502. PMC: 3525330. DOI: 10.1002/ajh.23171. View

19.

Noubiap J, Joko W, Nansseu J, Tene U, Siaka C . Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis. 2013; 17(10):e832-7. DOI: 10.1016/j.ijid.2012.12.007. View

20.

Mast A . Low hemoglobin deferral in blood donors. Transfus Med Rev. 2013; 28(1):18-22. PMC: 3944402. DOI: 10.1016/j.tmrv.2013.11.001. View